British Journal of Clinical PharmacologyVolume 3, Issue 4 p. 668-671 Free Access THE ASSESSMENT OF INTERACTIONS IN MAN BETWEEN TYRAMINE AND VILOXAZINE HYDROCHLORIDE, AN ANTIDEPRESSANT DRUG KARABI GHOSE, KARABI GHOSE Department of Clinical Pharmacology, St. Bartholomew's Hospital, London EC1A 7BISearch for more papers by this authorP. TURNER, P. TURNER Department of Clinical Pharmacology, St. Bartholomew's Hospital, London EC1A 7BISearch for more papers by this authorI.N. GRANT, I.N. GRANT Clinical Research Department, Imperial Chemical Industries Limited, Pharmaceuticals Division, Alderley Park, Macclesfield, SK10 4TG Department of Family Medicine, McMaster University, Medical Centre, Hamilton, Ontario, Canada.Search for more papers by this author KARABI GHOSE, KARABI GHOSE Department of Clinical Pharmacology, St. Bartholomew's Hospital, London EC1A 7BISearch for more papers by this authorP. TURNER, P. TURNER Department of Clinical Pharmacology, St. Bartholomew's Hospital, London EC1A 7BISearch for more papers by this authorI.N. GRANT, I.N. GRANT Clinical Research Department, Imperial Chemical Industries Limited, Pharmaceuticals Division, Alderley Park, Macclesfield, SK10 4TG Department of Family Medicine, McMaster University, Medical Centre, Hamilton, Ontario, Canada.Search for more papers by this author First published: August 1976 https://doi.org/10.1111/j.1365-2125.1976.tb04893.xCitations: 5 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References BAYLISS, P.F.C. & CASE, D.E. (1975). Blood level studies with viloxazine hydrochloride in man. Br. J. clin. Pharmac., 2, 209– 214. BAYLISS, P.F.C., DEWSBURY, A.R., DONALD, J.F., HARCUP, J.W., MAYER, M., MILLION, R., MOLLA, A.L., MURPHY, J.E., PLANT, B. & SHAOUL, E. (1974). A double blind controlled trial of ‘Vivalan’ (viloxazine hydrochloride) and imipramine hydrochloride in the treatment of depression in general practice. J. int. med. Res., 2, 260. BEREEN, F.J. (1973). A new potential antidepressive. Lancet, i, 379– 380. BURN, J.H. & RAND, M.J. (1958). The action of sympathomimetic amines in animals treated with reserpine. J. Physiol. Lond., 144, 314. COX, T. & TYE, N. (1975). The effects of amphetamine, imipramine and ICI 58,834 (‘Vivalan’), a potential antidepressant, on unconditional behaviour in rats. Psychopharmacologia (Berl.), 40, 297. EKDAWI, M.Y. (1975). Viloxazine (‘Vivalan’) comparison with imipramine. J. int. med. Res., 3 (Suppl. 3), 75. GOODWIN, B.L., JOHNSON, R.D., RUTHVEN, C.R.J. & SANDLER, M. (1975). Effect of viloxazine (‘Vivalan’) on the urinary excretion of catecholamines and their metabolites. J. int. med. Res., 3 (Suppl. 3), 57. GREENWOOD, D.T. (1975). Animal pharmacology of viloxazine (‘Vivalan’). J. int. med. Res., 3 (Suppl. 3), 18. HERTTING, G., AXELROD, J. & WHITBY, L.G. (1961). Effect of drugs on the uptake and metabolism of 3H-norepinephrine. J. Pharmac. exp. Ther., 134, 146– 153. IVERSEN, L.L. (1965). Inhibition of noradrenaline uptake of drugs. J. Pharm. Pharmac., 17, 62– 64. JOHNSON, E.S., SOUTHGATE, P.J., SUDGEN, R.F. & WHITE, A.C. (1972). The pharmacology of Wy-23409, a new antidepressive agent. Fifth int. Congress Pharmacology July 23–28.. KOPIN, I.J., FISCHER, J.E., MUSACCHIO, J.M., HORST, W.D. & WEISE, V.K. (1965). False neurochemical transmitters and the mechanism of sympathetic blockade by monoamineoxidase inhibitors. J. Pharmac. exp. Ther., 147, 186– 193. MAHAPATRA, S.B. (1975). Short term effects of viloxazine (‘Vivalan’) compared with placebo in depression: A double blind study. J. int. med. Res., 3 (Suppl. 3), 70. MALLION, K.B., TODD, A.H., TURNER, R.W., BAINBRIDGE, J.G., GREENWOOD, D.T., MADINAVEITIA, J., SOMERVILLE, A.R. & WHITTLE, B.A. (1972). 2-(2-ethoxyphenoxymethyl) tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent. Nature. Lond., 238, 157. PEET, M. (1973). Clinical trial of ICI 58,834-a potential antidepressant. J. int. med. Res., 1, 624– 626. PETTINGER, W.A., SOYANGCO, F.G. & OATES, J.A. (1968). Inhibition of monoamine oxidase in man by furazolidine. Clin. Pharmac. Ther., 9, 442– 447. PICHOT, P. (1975). A controlled multicentre therapeutic trial of viloxazine (‘Vivalan’). J. int. med. Res., 3 (Suppl. 3), 80. WALTER, C.J.S. (1971). Clinical significance of plasma imipramine levels. Proc. Roy. Soc. Med., 64, 282. Citing Literature Volume3, Issue4August 1976Pages 668-671 ReferencesRelatedInformation